Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-04-24 8:02 pm Purchase |
2025-04-22 | 13D | Panbela Therapeutics, Inc. PBLA |
Nant Capital, LLC | 32,432,432 86.980% |
30,005,366![]() (+1236.28%) |
Filing History |
2024-10-29 7:40 pm Purchase |
2024-10-22 | 13D | Panbela Therapeutics, Inc. PBLA |
Nant Capital, LLC | 2,427,066 33.330% |
2,427,066![]() (New Position) |
Filing History |
2024-02-13 8:10 pm Unchanged |
2023-12-31 | 13G | Panbela Therapeutics, Inc. PBLA |
Lind Global Fund II LP | 0 0.000% |
0 (Unchanged) |
Filing History |
2023-02-14 2:45 pm Purchase |
2022-12-31 | 13G | Panbela Therapeutics, Inc. PBLA |
Cullen Michael T. | 58 3.300% |
58![]() (New Position) |
Filing History |
2023-01-30 4:38 pm Purchase |
2023-01-30 | 13G | Panbela Therapeutics, Inc. PBLA |
Lind Global Fund II LP | 983 9.900% |
983![]() (New Position) |
Filing History |
2022-02-14 5:20 pm Purchase |
2021-12-31 | 13G | Panbela Therapeutics, Inc. PBLA |
Cullen Michael T. | 36 6.300% |
2![]() (+5.57%) |
Filing History |
2021-02-16 4:06 pm Purchase |
2020-12-31 | 13G | Panbela Therapeutics, Inc. PBLA |
Cullen Michael T. | 34 8.200% |
34![]() (New Position) |
Filing History |
2021-02-16 4:01 pm Purchase |
2020-12-31 | 13G | Panbela Therapeutics, Inc. PBLA |
Schemel Donald Robert | 19 4.600% |
19![]() (New Position) |
Filing History |
2020-09-08 5:15 pm Purchase |
2020-08-28 | 13G | SUN BIOPHARMA INC SNBP |
Armistice Capital, LLC | 497,029 4.990% |
497,029![]() (New Position) |
Filing History |